REHATRON™alpha - Introduction
REHATRON™alpha – the non-invasive induction therapy (N.I.I.T.) opens up new possibilities for the treatment of numerous ailments and illnesses
Doctors and therapists who work with the first registered nano-impulse device REHATRON™alpha are in agreement on it: the promising technology of the non-invasive induction therapy has an enormous therapeutic potential being at the same time a human and harmless type of treatment without physical contact which can be used for a wide range of indications due to its functioning.
REHATRON™alpha was developed on the basis of the findings of significant scientists of the past century like Nikola Tesla, Georges Lakhovsky, Antoine Priore and Raymond Rife who had discovered that the impact of energy impulses of a higher frequency on the organism can regenerate cells and cell clusters and eliminate viruses and bacteria in the area of nano seconds and micro seconds. However, it had not been feasible to put such findings into practice in former days, since the technical materials and components which would have guaranteed the supply of high energy and, above all, a stable and durable form of application were not sufficiently developed.
Only with the fundamental conception and development of REHATRON™alpha it became possible to make a well-developed, stable and safe technology work which corresponds to today’s physiological, physical and medical insights and can be applied successfully in practice.
In another words, REHATRON™alpha is an innovative, medical-technological therapy system which generates energy to 120 million Watt for a short time that can be transferred to the organism via a special, seven-times secured treatment loop. The spectrum of frequency extends to 220 kilo Hertz, thus REHATRON™alpha is – and this is important for comprehension – not comparable with common magnetic-field, shortwave, pulsating microwave devices etc.
Though it is a common goal of all methods which work with magnetic impulses and/or frequencies to regulate or increase the potential of ill or degenerated cells; the non-invasive induction therapy with REHATRON™alpha assumes that a healthy cell which has a membrane potential of 80-100 mV (milli Volt) can only be charged successfully with energy which lies above the membrane potential, while classic magnetic-field therapy tries to keep the intensity below 10 mT (milli Tesla) considering that this area is below the intensity of magnetic field of the earth.
Furthermore, according to the newest insights cells possess a stable cell structure which requires an effective, transmembrane, intracellular energy in the area of REHATRON™alpha. A 12-Volt battery for example can only be charged with a charger which has a potential above 12 Volt.
In the past five years practices, institutes and clinics achieved results with REHATRON™alpha which open up new dimensions for the therapy of those diseases which are caused by the bioenergetic metabolism of organic cells – therefore nearly all diseases.
1. REHATRON™alpha is based on the findings of significant scientists like Nikola Tesla, A. Priore, G. Dotto, R. R. Rife and others
2. REHATRON™alpha was planned and developed by a small team from Salzburg/Austria – contrary to circulating statements – in 2002 and began with the approval procedure in 2003
3. REHATRON™alpha was approved in 2005 as the first medical and technical “non-invasive induction therapy“
4. Since 2007 REHATRON™alpha has been produced by the consortium Novotech and is being continually optimized so that the devices work with a state-of-the-art technology
5. Since summer 2011 the consortium Novotech is the owner of REHATRON™alpha
6. Nowadays, more than 150 doctors, clinics and therapists work with REHATRON™alpha all over Europe, whereas some users work with two or more REHATRON™alpha devices at the same time
7. Up to present several millions of treatments have already been carried out
Conclusion:
REHATRON™alpha is not only the original, but also the well-deserved market leader in the area of high-frequency impulse devices.
